Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Comment by zenvestingon Feb 10, 2015 10:18pm
129 Views
Post# 23416598

RE:RE:RE:RE:Highlighted in SmallCap Discoveries

RE:RE:RE:RE:Highlighted in SmallCap DiscoveriesThanks for quoting me bashermasher, I'm honored, but you took my quote out of context. I was replying to a post about one of the paid subscribers leaking their latest pick.....and the guy I was responding to said leaking the pick was like kicking subscribers in the nuts, but obviously subscribers benefit from having the largest most liquid market for their stock...so anyway......yes, I think there's a bit of a conflict of interest between the newsletter writers and the newsletter subscribers. Please make no mistake, the SCD writer's began coverage on this stock more than a year ago near $0.20.....and suscriber, or non-subscriber, I think we all can agree that you are truly a nutjob.....and your postings are a complete waste of time for serious investors.
Bullboard Posts